表紙:遠隔医療の世界市場:予測(2023年~2028年)、業界動向、成長、インフレの影響、企業の機会分析
市場調査レポート
商品コード
1185047

遠隔医療の世界市場:予測(2023年~2028年)、業界動向、成長、インフレの影響、企業の機会分析

Telemedicine Market, Global Forecast 2023-2028, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis

出版日: | 発行: Renub Research | ページ情報: 英文 150 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
遠隔医療の世界市場:予測(2023年~2028年)、業界動向、成長、インフレの影響、企業の機会分析
出版日: 2023年01月01日
発行: Renub Research
ページ情報: 英文 150 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の遠隔医療の市場規模は、2022年に540億2,000万米ドルとなりました。同市場は今後も拡大し、2028年までに1,975億5,000万米ドルに達する見込みです。

当レポートでは、世界の遠隔医療市場について調査し、市場の概要とともに、タイプ別、用途別、モダリティ別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場力学

  • 促進要因
  • 課題

第5章 世界の遠隔医療市場

第6章 市場シェア- 世界の遠隔医療市場

  • タイプ別
  • 用途別
  • モダリティ別
  • エンドユーザー別
  • 地域別

第7章 タイプ別 - 世界の遠隔医療市場

  • 製品
  • サービス

第8章 用途別 - 世界の遠隔医療市場

  • 電話相談
  • テレパソロジー
  • テレカーディオロジー
  • 遠隔手術
  • テレラジオロジー
  • 遠隔皮膚科
  • 遠隔精神医学
  • その他

第9章 モダリティ別 - 世界の遠隔医療市場

  • リアルタイム遠隔医療
  • リモート患者モニタリング

第10章 エンドユーザー別 - 世界の遠隔医療市場

  • 病院
  • 診断センター
  • 外来手術センター
  • 専門センター
  • その他

第11章 地域別 - 世界の遠隔医療市場

  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第12章 企業分析

  • CEVA, Inc.
  • Eli Lilly and Company
  • Bayer AG
  • Merck & Co. Inc
  • Teladoc Health, Inc
図表

List of Figures

  • Figure-01: Global - Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-02: Global - Forecast for Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-03: Types - Products Market (Billion US$), 2018 - 2022
  • Figure-04: Types - Forecast for Products Market (Billion US$), 2023 - 2028
  • Figure-05: Types - Services Market (Billion US$), 2018 - 2022
  • Figure-06: Types - Forecast for Services Market (Billion US$), 2023 - 2028
  • Figure-07: Application - Teleconsultation Market (Billion US$), 2018 - 2022
  • Figure-08: Application - Forecast for Teleconsultation Market (Billion US$), 2023 - 2028
  • Figure-09: Application - Telepathology Market (Billion US$), 2018 - 2022
  • Figure-10: Application - Forecast for Telepathology Market (Billion US$), 2023 - 2028
  • Figure-11: Application - Telecardiology Market (Billion US$), 2018 - 2022
  • Figure-12: Application - Forecast for Telecardiology Market (Billion US$), 2023 - 2028
  • Figure-13: Application - Telesurgery Market (Billion US$), 2018 - 2022
  • Figure-14: Application - Forecast for Telesurgery Market (Billion US$), 2023 - 2028
  • Figure-15: Application - Teleradiology Market (Billion US$), 2018 - 2022
  • Figure-16: Application - Forecast for Teleradiology Market (Billion US$), 2023 - 2028
  • Figure-17: Application - Teledermatology Market (Billion US$), 2018 - 2022
  • Figure-18: Application - Forecast for Teledermatology Market (Billion US$), 2023 - 2028
  • Figure-19: Application - Telepsychiatry Market (Billion US$), 2018 - 2022
  • Figure-20: Application - Forecast for Telepsychiatry Market (Billion US$), 2023 - 2028
  • Figure-21: Application - Others Market (Billion US$), 2018 - 2022
  • Figure-22: Application - Forecast for Others Market (Billion US$), 2023 - 2028
  • Figure-23: Modality - Real Time Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-24: Modality - Forecast for Real Time Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-25: Modality - Remote Patient Monitoring Market (Billion US$), 2018 - 2022
  • Figure-26: Modality - Forecast for Remote Patient Monitoring Market (Billion US$), 2023 - 2028
  • Figure-27: End User - Hospital Market (Billion US$), 2018 - 2022
  • Figure-28: End User - Forecast for Hospital Market (Billion US$), 2023 - 2028
  • Figure-29: End User - Diagnostic Center Market (Billion US$), 2018 - 2022
  • Figure-30: End User - Forecast for Diagnostic Center Market (Billion US$), 2023 - 2028
  • Figure-31: End User - Ambulatory Surgical Center Market (Billion US$), 2018 - 2022
  • Figure-32: End User - Forecast for Ambulatory Surgical Center Market (Billion US$), 2023 - 2028
  • Figure-33: End User - Specialty Center Market (Billion US$), 2018 - 2022
  • Figure-34: End User - Forecast for Specialty Center Market (Billion US$), 2023 - 2028
  • Figure-35: End User - Others Market (Billion US$), 2018 - 2022
  • Figure-36: End User - Forecast for Others Market (Billion US$), 2023 - 2028
  • Figure-37: North America - Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-38: North America - Forecast for Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-39: Europe - Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-40: Europe - Forecast for Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-41: Asia Pacific - Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-42: Asia Pacific - Forecast for Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-43: Latin America - Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-44: Latin America - Forecast for Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-45: Middle East & Africa - Telemedicine Market (Billion US$), 2018 - 2022
  • Figure-46: Middle East & Africa - Forecast for Telemedicine Market (Billion US$), 2023 - 2028
  • Figure-47: CEVA, Inc. - Global Revenue (Million US$), 2018 - 2022
  • Figure-48: CEVA, Inc. - Forecast for Global Revenue (Million US$), 2023 - 2028
  • Figure-49: Eli Lilly and Company - Global Revenue (Billion US$), 2018 - 2022
  • Figure-50: Eli Lilly and Company - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-51: Bayer AG - Global Revenue (Billion US$), 2018 - 2022
  • Figure-52: Bayer AG - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-53: Merck & Co. Inc - Global Revenue (Billion US$), 2018 - 2022
  • Figure-54: Merck & Co. Inc - Forecast for Global Revenue (Billion US$), 2023 - 2028
  • Figure-55: Teladoc Health, Inc. - Global Revenue (Million US$), 2018 - 2022
  • Figure-56: Teladoc Health, Inc. - Forecast for Global Revenue (Million US$), 2023 - 2028

List of Tables

  • Table-01: Global - Telemedicine Market Share by Type (Percent), 2018 - 2022
  • Table-02: Global - Forecast for Telemedicine Market Share by Type (Percent), 2023 - 2028
  • Table-03: Global - Telemedicine Market Share by Application (Percent), 2018 - 2022
  • Table-04: Global - Forecast for Telemedicine Market Share by Application (Percent), 2023 - 2028
  • Table-05: Global - Telemedicine Market Share by Modality (Percent), 2018 - 2022
  • Table-06: Global - Forecast for Telemedicine Market Share by Modality (Percent), 2023 - 2028
  • Table-07: Global - Telemedicine Market Share by End User (Percent), 2018 - 2022
  • Table-08: Global - Forecast for Telemedicine Market Share by End User (Percent), 2023 - 2028
  • Table-09: Global - Telemedicine Market Share by Region (Percent), 2018 - 2022
  • Table-10: Global - Forecast for Telemedicine Market Share by Region (Percent), 2023 - 2028
目次

Global Telemedicine Market will reach to US$ 197.55 Billion by 2028 according to Renub Research. Telemedicine, also called e-medicine, is the remote delivery of healthcare services, including consultations and examinations, over the telecommunications infrastructure. By using the latest telemedicine features, practice can reap numerous benefits. Telemedicine can reduce medical costs, improve efficiency and profitability, and offer patients better access to medical services.

Telemedicine has shown tremendous growth in the last five years. Telemedicine helps patients to connect with physicians remotely and also aids in reducing the price burden of healthcare. Due to these advantages, physicians and hospitals look forward to adopting digital health technologies. In addition, Telemedicine has also triggered the government to reimbursement policies and develop regulations around telehealth. Telemedicine Market size surpassed US$ 54.02 Billion in 2022.

Introduction of Al-based clinics to create multiple opportunities in the field of Telemedicine

Artificial intelligence-powered booths in local malls have emerged in the last few years. The system includes an intelligent medicine cabinet that dispenses over 100 medications. In addition, the AI machine collects the patient's medical history and provides a diagnosis strategy, which is transferred to a clinical expert. These small clinics are called "One-Minute Clinics." These clinics connect patients with a physician on 'Ping, Doctor's in-house medical team.

Such AI-based clinics can be set up anywhere from shopping mall to school and pharmacies to highway service stations. Moreover, introducing digitally advanced medical devices connected, integrated, and wirelessly with mobile phones would also surge the market growth. Hence, such innovations in the digital health field hold tremendous opportunities for the telemedicine industry to exhibit positive development across the globe.

Worldwide Tele-medicine Market to grow with a staggering CAGR of 24.12% from 2023 to 2028

By Type Analysis: The telemedicine market is further bifurcated based on type into services and products. In Telemedicine, reducing waiting time for consultations and referrals is one of the main reasons for the increasing number of patients providing or deploying consultation services, which, in turn, is favoring the services segment. Further, Worldwide Tele-medicine Industry is projected to grow with a double digit CAGR of 24.12% from 2023 to 2028.

Application Analysis: Teleconsultation and Teleradiology Accounts for most of the Revenue Share

Telemedicine is segmented into Teleconsultation, Telecardiology, Teledermatology, Telepathology, Telecardiology, Telesurgery, Telepsychiatry, and Others. Teleconsultation and Teleradiology accounted for most of the revenue share. The demand for Teleradiology increased rapidly in the past few years owing to various benefits such as faster diagnostics, precise imaging, lower costs, and elimination of the excess work of the radiologists.

The telecardiology segment will also grow due to the rising prevalence of cancer and cardiovascular diseases among the global population and the increasing adoption of telemedicine platforms. Telemedicine provides a patient monitoring feature that has a cardiac device implanted. It improves patient care, so the demand for this segment is expected to grow.

Modality Analysis: The Real-time Segment is expected to grow due to rise in e-visits

Regarding the modality, the industry is segmented into real-time and Remote Patient Monitoring. The real-time segment is expected to grow due to the drastic rise in e-visits. On the other hand, the increasing application of telehealth in diagnosing diseases and radiology, especially in dermatology, is expected to favor the expansion of the remote patient monitoring segment. In addition, coupled with a significant increase in smartphone users, the rising internet penetration, even in rural areas, is projected to augment the growth of the Modality segment.

End User: Hospital Segment holds a Maximum Portion of the Market

The telemedicine market is segmented into hospitals, Diagnostics Centers, Ambulatory Surgical Centers, Specialty Centers, and Other. The hospital Segment holds a maximum portion of the market. The increasing number of service providers for virtual consultations, the increased use of telecommunications tools for training doctors in medical colleges, and several government-funded pilot programs for Telemedicine are the main factors poised to surge the hospital segment.

On the other hand, the diagnostic center segment is projected to show substantial market growth during the forecast period. The primary factors responsible for developing the diagnostic center segment are the rising geriatric population and significant cost-saving in the healthcare services expenditure.

Region: North American will hold the most Market Share

North American will hold the most market share due to significant players such as MDLive, Teladoc, and others, as well as increasing teleconsultations and strong government support, which are driving the market in this region. Europe is also the one of the most leading region in demand, which can be attributed to the rising prevalence of chronic diseases and the improving government guidelines for using digital health.

According to the British Skin Foundation, approx 100,000 new skin cancer cases are diagnosed annually in the United Kingdom. This poses a high-cost burden on the people of the country. Thus, the government of the United Kingdom deployed Telederm, which provides over 50,000 skin cancer diagnoses to NHS and private patients annually, resulting in adequate cost savings.

As smartphones and high cameras have opened new opportunities for the Asian market, many start-up companies, such as FirstCheck, InstaDoc, and others, are sprouting up in Asia, which is anticipated to foster the telemedicine market in the region. For example, in March 2021, India Brand Equity Foundation (IBEF) reported that the Indian government launched a telemedicine service eSanjeevani and completed around 3 million consultations nationwide. In addition, the growing number of ongoing pilot projects to overcome the shortage of doctors & physicians in recent years is expected to augment the growth in the MEA and Latin America.

Company Analysis

The telemedicine industry has made healthcare affordable and accessible to all. In addition, the increasing number of e-visits and expansion in behavioral health, radiology, cardiology, and others has risen in developing healthcare models and new business surrounding telehealth. As a result, the telemedicine market is slowly becoming highly competitive with the launch of new platforms and the entry of new players with massive funding. In May 2021, MediTelecare launched a direct-to-consumer mobile technology named MediTely. It was primarily designed for the old age population.

Renub Research new report titled "Global Telemedicine Market by Types (Products & Services), Application (Teleconsultation, Telepathology, Telecardiology, Telesurgery, Teleradiology, Teledermatology, Telepsychiatry, Others) Modality (Real-Time Telemedicine & Remote Patient Monitoring) End Users (Hospitals, Diagnostics Center, Ambulatory Surgical Center, Specialty Center & Others), Regions (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa) Company (CEVA Inc, Eli Lilly & Company, Bayer AG, Merck &Co.Inc)" provides a complete analysis of Telemedicine Market Industry Worldwide.

Types Outlook - Market has been covered from 2 viewpoints:

1. Products

2. Services

Application Outlook - Market has been covered from 8 viewpoints:

1. Teleconsultation

2. Telepathology

3. Telecardiology

4. Telesurgery

5. Teleradiology

6. Teledermatology

7. Telepsychiatry

8. Others

Modality Outlook - Market has been covered from 2 viewpoints:

1. Real Time Telemedicine

2. Remote Patient Monitoring

End Users Outlook - Market has been covered from 5 viewpoints:

1. Hospital

2. Diagnostic Center

3. Ambulatory Surgical Center

4. Specialty Center

5. Others

Region Outlook - Market has been covered from 5 viewpoints:

1. North America

2. Europe

3. Asia Pacific

4. Latin America

5. Middle East & Africa

All companies have been covered from 3 Viewpoints

  • Overview
  • Recent Development & Strategies
  • Financial Insight

Company Analysis

1. CEVA, Inc.

2. Eli Lilly and Company

3. Bayer AG

4. Merck & Co. Inc

5. Teladoc Health, Inc.

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Global Telemedicine Market

6. Market Share - Global Telemedicine Market

  • 6.1 By Types
  • 6.2 By Application
  • 6.3 By Modality
  • 6.4 By End User
  • 6.5 By Region

7. Types - Global Telemedicine Market

  • 7.1 Products
  • 7.2 Services

8. Application - Global Telemedicine Market

  • 8.1 Teleconsultation
  • 8.2 Telepathology
  • 8.3 Telecardiology
  • 8.4 Telesurgery
  • 8.5 Teleradiology
  • 8.6 Teledermatology
  • 8.7 Telepsychiatry
  • 8.8 Others

9. Modality - Global Telemedicine Market

  • 9.1 Real Time Telemedicine
  • 9.2 Remote Patient Monitoring

10. End User - Global Telemedicine Market

  • 10.1 Hospital
  • 10.2 Diagnostic Center
  • 10.3 Ambulatory Surgical Center
  • 10.4 Specialty Center
  • 10.5 Others

11. Region - Global Telemedicine Market

  • 11.1 North America
  • 11.2 Europe
  • 11.3 Asia Pacific
  • 11.4 Latin America
  • 11.5 Middle East & Africa

12. Company Analysis

  • 12.1 CEVA, Inc.
    • 12.1.1 Overview
    • 12.1.2 Recent Development
    • 12.1.3 Financial Insight
  • 12.2 Eli Lilly and Company
    • 12.2.1 Overview
    • 12.2.2 Recent Development
    • 12.2.3 Financial Insight
  • 12.3 Bayer AG
    • 12.3.1 Overview
    • 12.3.2 Recent Development
    • 12.3.3 Financial Insight
  • 12.4 Merck & Co. Inc
    • 12.4.1 Overview
    • 12.4.2 Recent Development
    • 12.4.3 Financial Insight
  • 12.5 Teladoc Health, Inc.
    • 12.5.1 Overview
    • 12.5.2 Recent Development
    • 12.5.3 Financial Insight